Clinical trial
The Effect of Remimazolam on Remifentanil-induced Hyperalgesia
NCT05866315 is registered in ClinicalTrials.gov with Wonkwang University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Remimazolam on Remifentanil-induced Hyperalgesia
- Lead sponsor
- Wonkwang University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 19, 2023
- Completion date
- September 15, 2023
- Enrollment
- 108 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hyperalgesia, mechanical